3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Breast Neoplasms
21
Carcinoma, Non-Small-Cell Lung
12
Rectal Neoplasms
9
Glioblastoma
9
Esophageal Neoplasms
9
Squamous Cell Carcinoma of Head and Neck
8
Stomach Neoplasms
7
Pancreatic Neoplasms
7
Lung Neoplasms
6
Head and Neck Neoplasms
6
Colorectal Neoplasms
5
Sarcoma
4
Ovarian Neoplasms
4
Neoplasms
4
Fallopian Tube Neoplasms
4
Colonic Neoplasms
3
Brain Neoplasms
3
Adenocarcinoma of Lung
3
Urinary Bladder Neoplasms
2
Osteosarcoma
2
Melanoma
2
Glioma
2
Carcinoma, Ovarian Epithelial
2
Carcinoma, Intraductal, Noninfiltrating
2
Carcinoma
2
Adenocarcinoma Of Esophagus
2
Xerostomia
1
Wilms Tumor
1
Urethral Neoplasms
1
Triple Negative Breast Neoplasms
1
Interventions
Clomiphene
5
Letrozole
4
follitropin alfa
2
Medroxyprogesterone Acetate
2
follitropin beta
1
drospirenone and ethinyl estradiol combination
1
drospirenone
1
Urofollitropin
1
Thyrotropin
1
Testosterone
1
Surgical Procedures, Operative
1
Sugars
1
Raloxifene Hydrochloride
1
Progestins
1
Progesterone
1
Oils
1
Menotropins
1
Luteinizing Hormone
1
Leuprolide
1
Goserelin
1
Glycoprotein Hormones, alpha Subunit
1
Flutamide
1
Ethinyl Estradiol
1
Cyclophosphamide
1
Body Mass Index
1
Blood Urea Nitrogen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Infertility
×
Surgical Procedures, Operative
×
Clear all
NCT00767338
2013-07-02
VIA
Yale University
Phase 3
Terminated
3 enrolled
3 charts